NCT05543577 is a clinical trial of Questionnaire in Monkey Pox, sponsored by Beni-Suef University.

Who is sponsoring NCT05543577?

NCT05543577 is sponsored by Beni-Suef University.

What drugs are being tested in NCT05543577?

Interventions in NCT05543577: Questionnaire.

What condition does NCT05543577 study?

NCT05543577 studies Monkey Pox.

Is NCT05543577 still recruiting?

NCT05543577 is currently completed. Last updated 5 December 2023.

Last reviewed 2023-12-05 · How we verify

NCT05543577

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessing the Preparedness and Knowledge of Pharmacists in the Current Monkeypox Outbreak

Completed Last updated 5 December 2023

What this trial tests

trial testing Questionnaire in Monkey Pox in 500 participants. Completed in 1 December 2022.

Timeline

14 September 2022

Primary endpoint
1 November 2022

1 December 2022

Quick facts

Lead sponsor	Beni-Suef University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	500
Start date	14 September 2022
Primary completion	1 November 2022
Estimated completion	1 December 2022
Sites	1 location across Egypt

Drugs / interventions tested

Questionnaire

Conditions studied

Monkey Pox — all drugs for Monkey Pox →

Sponsor

Beni-Suef University

Who can join

Eligibility, any sex, with Monkey Pox. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

General objective: to measure the preparedness of pharmacists and medical interns about monkeypox Specific objectives: to evaluate the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Evaluating the advancements and efficacies in pharmacological Mpox treatments: a comprehensive review.
Hudu SA, Saadi N, Tahir A, Jimoh AO, et al · · 2025 · cited 1× · PMID 41098827 · DOI 10.3389/fphar.2025.1654467
Current Clinical Trials for the Monkeypox Virus
Kandeel M. · · 2023

Verify or expand the search:

Other recruiting trials for Monkey Pox

Currently open trials in the same condition.

NCT07085611 — Neutralizing Power of Serum Antibodies - 2 · NA · recruiting
NCT05627713 — Clinical and Biological Aspects of the MONKEYPOX Disease · NA · recruiting

Other Beni-Suef University trials

Trials by the same sponsor.

NCT07536347 — Effect of Adding PNF to IMT on Weaning Off MV · NA · not yet recruiting
NCT07494240 — Effects of Changes in Driving Pressure on Intraoperative Pulmonary Dynamic Compliance and PaO₂/FiO₂ Ratio in Laparoscopi · NA · not yet recruiting
NCT07506499 — Cardiac Rehabilitation in Decompensated Heart Failure · NA · recruiting
NCT07482631 — Robotic Glove Training on Hand Function in Unilateral Cerebral Palsy · NA · not yet recruiting
NCT07509736 — Effect of Pulmonary Rehabilitation in Females With Acute Exacerbation of COPD Induced by Biomass Fuel Smoke · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05543577 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beni-Suef University
Last refreshed: 5 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05543577.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing